Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
20.95
+0.16 (0.77%)
At close: Aug 1, 2025, 4:00 PM
20.50
-0.45 (-2.15%)
After-hours: Aug 1, 2025, 6:15 PM EDT

Model N Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Selling, General & Admin
494123.7921.9111.924.04
Upgrade
Research & Development
144.25126.1778.2368.9922.4845.21
Upgrade
Operating Expenses
193.25167.17102.0190.934.449.25
Upgrade
Operating Income
-193.25-167.17-102.01-90.9-34.4-49.25
Upgrade
Interest Expense
-7.51-7.63-3.79-0.99-0.02-0.17
Upgrade
Interest & Investment Income
23.4320.717.981.750.020.01
Upgrade
Other Non Operating Income (Expenses)
1.871.941.831.9-0.06
Upgrade
EBT Excluding Unusual Items
-175.46-152.15-95.99-88.25-34.41-49.34
Upgrade
Merger & Restructuring Charges
------3
Upgrade
Gain (Loss) on Sale of Investments
----0.81-0.89-
Upgrade
Gain (Loss) on Sale of Assets
----2.69-
Upgrade
Other Unusual Items
------1.08
Upgrade
Pretax Income
-175.46-152.15-95.99-89.06-32.61-53.41
Upgrade
Income Tax Expense
000000
Upgrade
Net Income
-175.46-152.15-95.99-89.06-32.61-53.41
Upgrade
Net Income to Common
-175.46-152.15-95.99-89.06-32.61-53.41
Upgrade
Shares Outstanding (Basic)
59554327130
Upgrade
Shares Outstanding (Diluted)
59554327130
Upgrade
Shares Change (YoY)
27.09%29.55%60.73%97.76%4099.14%8.34%
Upgrade
EPS (Basic)
-3.00-2.75-2.25-3.35-2.43-166.93
Upgrade
EPS (Diluted)
-3.00-2.75-2.25-3.35-2.43-166.93
Upgrade
Free Cash Flow
-156.41-135.65-92.24-67.66-23.71-34.91
Upgrade
Free Cash Flow Per Share
-2.67-2.45-2.16-2.55-1.76-109.10
Upgrade
EBITDA
-193.07-167.07-101.99-90.73-34.23-48.99
Upgrade
D&A For EBITDA
0.180.110.020.180.180.25
Upgrade
EBIT
-193.25-167.17-102.01-90.9-34.4-49.25
Upgrade
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q